← Leaderboards
Ashley Smuder
University Of Florida
$4,324,646
Attributed
$4,896,521
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,896,521 · 3
By mechanism
R01$4,896,521 · 3
Top collaborators
- David D Fuller3 shared
Most similar at University Of Florida
Same institution · by research overlap
- David D Fuller$12,096,681
- Gordon Stewart Mitchell$30,134,377
- Clayton E Mathews$19,414,489
- Paul J. Reier$4,066,277
- Michael Aron Lane$3,021,942
Others in their field
Other Emerging Leaders on “Oxidation-Reduction”
- Tomohiro Nakamura · Scripps Research Institute, The$9,036,296
- Angelo D'alessandro · University Of Colorado Denver$6,933,310
- Gina Marie Denicola · H. Lee Moffitt Cancer Ctr & Res Inst$5,352,814
- Song Lin · Cornell University$5,134,228
- Matthew A Nystoriak · University Of Louisville$4,288,754
- Valentin Cracan · Massachusetts General Hospital$4,231,012
Research focus
Oxidation-ReductionProductionFoundationsAttenuatedPathologyMolecularAntisense OligonucleotidesAntioxidantsExperimental StudyUp-RegulationReactive Oxygen SpeciesRecombinant Adeno-Associated Virus (Raav)Oxidative StressExposure ToOverexpressionLeadFutureIronBiologicalCarrier ProteinsFree RadicalsConsensusAnti-CancerCytochrome C Reductase
Grant awards (14)
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2023 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$361,119
R01 · FY2023 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2022 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2022 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$362,698
R01 · FY2022 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$398,821
R01 · FY2021 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2021 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2021 · HL · contact PI
Hyperbaric oxygen therapy mitigates respiratoryneuromuscular pathology after spinal cord injury$381,250
R01 · FY2020 · HL
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$374,408
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$365,434
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$39,778
R01 · FY2020 · HL · contact PI
Doxorubicin cardiotoxicity and the protective effects of exercise$366,619
R01 · FY2019 · HL · contact PI
Doxorubicin-induced respiratory dysfunction and the protective effects of exercise$360,670
R01 · FY2019 · HL · contact PI